NewsRx

Search our medical news database

Research

John Wiley & Sons, Inc. Announces First Quarter Fiscal Year 2009 Results

Published in Surgery Litigation and Law Weekly, September 26th, 2008

John Wiley & Sons, Inc. (NYSE: JWa & JWb) reported revenue of $402 million for the first quarter of fiscal year 2009 ended July 31, 2008, a 3% increase over the same period of fiscal year 2008, or 2% excluding favorable foreign exchange.

Earnings per diluted share for the first quarter increased 19% over the first quarter of fiscal year 2008, excluding a one-time tax benefit that was accretive to EPS by $0.26 last year. The increase was principally due to lower debt financing costs and a $4.6 million ($0.08 per share) insurance settlement. On a U.S. GAAP basis, earnings per diluted share in the first quarter was $0.50 compared to $0.68 for the same quarter of the prior...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook